Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Europe heparin sodium market is occupied by local suppliers and Chinese manufacturers. Currently, there are many heparin sodium products producing companies in the Europe heparin sodium industry. The main market players are Shenzhen Hepalink, Nanjing King-friend, Dongcheng Biochemicals, Pharma Action, Opocrin and Bioibérica. The Europe sales of heparin sodium will increase to 72006 Kg in 2017 from 66667 Kg in 2012 with average growth rate of 1.56%.
The Europe consumption value of heparin sodium decreases with the 11.04% average growth rate. France and Germany are the main consumption regions. In 2016, these two regions occupied 58.34% of the Europe consumption volume in total.
Heparin sodium production methods include salt solution method and enzyme extraction method. With medical effect of heparin sodium, the downstream application industries will need more heparin sodium products. So, heparin sodium has a huge market potential in the future. Manufacturers are trying to produce good performance heparin sodium through improving technology.
The major raw materials for heparin sodium products are fresh intestine, pancreatic enzymes, ion exchange resin, preservative other auxiliary materials. Fluctuations in the price of the upstream product will impact on the production cost of heparin sodium. The production cost of heparin sodium is also an important factor which could impact the price of heparin sodium.
We tend to believe this industry is a rising industry, and the consumption increasing degree will show a smooth growth curve. According to the economy development status, the price presents decreasing trend from 2012 to 2017. And, there is fluctuation in gross margin.
The global Heparin Sodium market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Heparin Sodium volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heparin Sodium market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Shenzhen Hepalink
Nanjing King-friend
Dongcheng Biochemicals
Changzhou Qianhong Bio-pharma
Changshan Biochemical
Dongying Tiandong Pharmaceutical
Xinbai Pharmaceuticals
SPL
Bioibérica
Baxter
Opocrin
Aspen Oss
Pharma Action
Pfizer
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Heparin Sodium
Heparin Calcium
Segment by Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Other
Summary:
Get latest Market Research Reports on Heparin Sodium . Industry analysis & Market Report on Heparin Sodium is a syndicated market report, published as Global Heparin Sodium Market Research Report 2019. It is complete Research Study and Industry Analysis of Heparin Sodium market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.